CIK 0001582313 · Large accelerated filer
Xenon Pharmaceuticals Inc.
Sign in to watch- Ticker
- XENE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- EIN
- 980661854
- Phone
- (604) 484-3300
- Business address
- 200 - 3650 GILMORE WAY, BURNABY, British Columbia, Canada
- Open-market buys, last 90 days
- $1,681,140
- in 2 filings
- Open-market sales, last 90 days
- $425,829
- in 1 filing, $426K under 10b5-1 plans
Net +$1,255,311. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-07 | GANNON STEVEN Director | Sale | −5,000 | $46.25 | $231K | 9,000 |
| 2024-03-07 | GANNON STEVEN Director | Sale | −5,000 | $46.30 | $232K | 4,000 |
| 2024-03-07 | GANNON STEVEN Director | Sale | −2,000 | $46.20 | $92K | 2,000 |
| 2023-12-29 | ROBIN SHERRINGTON EVP, Strategy & Innovation | Other disposition | −8,398 | 8,398 | ||
| 2023-12-19 | AZAB MOHAMMAD Director | Option exercise | +823 | $9.85 | $8K | 70,728 |
| 2023-12-19 | AZAB MOHAMMAD Director | Option exercise | +3,497 | $9.85 | $34K | 74,225 |
| 2023-12-19 | AZAB MOHAMMAD Director | Option exercise · Stock Option (Right to Buy) | −823 | 0 | ||
| 2023-12-19 | AZAB MOHAMMAD Director | Option exercise · Stock Option (Right to Buy) | −3,497 | 0 | ||
| 2023-12-14 | PATOU GARY Director | Sale | −7,598 | $41.05 | $312K | 4,902 |
| 2023-12-13 | PATOU GARY Director | Option exercise | +6,378 | $9.85 | $63K | 29,951 |
| 2023-12-13 | PATOU GARY Director | Shares withheld for taxes | −1,278 | $39.68 | $51K | 28,673 |
| 2023-12-13 | PATOU GARY Director | Sale | −5,100 | $38.94 | $199K | 23,573 |
| 2023-12-13 | PATOU GARY Director | Option exercise | +2,880 | $9.85 | $28K | 26,453 |
| 2023-12-13 | PATOU GARY Director | Shares withheld for taxes | −577 | $39.68 | $23K | 25,876 |
| 2023-12-13 | PATOU GARY Director | Sale | −2,303 | $39.10 | $90K | 23,573 |
| 2023-12-13 | PATOU GARY Director | Option exercise | +5,144 | $9.00 | $46K | 28,717 |
| 2023-12-13 | PATOU GARY Director | Shares withheld for taxes | −1,167 | $39.68 | $46K | 27,550 |
| 2023-12-13 | PATOU GARY Director | Sale | −3,977 | $39.84 | $158K | 23,573 |
| 2023-12-13 | PATOU GARY Director | Sale | −7,598 | $41.05 | $312K | 4,902 |
| 2023-12-13 | PATOU GARY Director | Option exercise · Stock Option (Right to Buy) | −6,378 | 0 |
Page 10 of 16 · 308 trades